EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
121 hedge funds and large institutions have $1.45B invested in Eidos Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 24 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
37% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 38
47% less call options, than puts
Call options by funds: $5.02M | Put options by funds: $9.49M
Holders
121
Holding in Top 10
6
Calls
$5.02M
Puts
$9.49M
Top Buyers
| 1 | +$78.9M | |
| 2 | +$39.1M | |
| 3 | +$36.2M | |
| 4 |
DAM
DLD Asset Management
New York
|
+$31.5M |
| 5 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
+$24.2M |
Top Sellers
| 1 | -$109M | |
| 2 | -$50.2M | |
| 3 | -$21.8M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$19.2M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$15.5M |